Authors: Ebert, U Grossmann, M Oertel, R Gramatte, T Kirch, W

Citation: U. Ebert et al., Pharmacokinetic-pharmacodynamic modeling of the electroencephalogram effects of scopolamine in healthy volunteers, J CLIN PHAR, 41(1), 2001, pp. 51-60

Authors: Schwarz, UI Gramatte, T Krappweis, J Oertel, R Kirch, W

Citation: Ui. Schwarz et al., P-glycoprotein inhibitor erythromycin increases oral bioavailability of talinolol in humans, INT J CL PH, 38(4), 2000, pp. 161-167

Authors: Scheepe, JR Braun, PM Bross, S Weiss, J Zendler, S Gramatte, T Alken, P Junemann, KP

Citation: Jr. Scheepe et al., A standardized model for in vivo investigations of anticholinergic effectson bladder function, salivation and electromyographic characteristics of the detrusor, AKT UROL, 31(5), 2000, pp. 311-316

Authors: Gramatte, T Oertel, R

Citation: T. Gramatte et R. Oertel, Intestinal secretion of intravenous talinolol is inhibited by luminal R-verapamil, CLIN PHARM, 66(3), 1999, pp. 239-245

Authors: Schwarz, UI Gramatte, T Krappweis, J Berndt, A Oertel, R von Richter, O Kirch, W

Citation: Ui. Schwarz et al., Unexpected effect of verapamil on oral bioavailability of the beta-blockertalinolol in humans, CLIN PHARM, 65(3), 1999, pp. 283-290